대상포진 치료제 시장은 2023-2028년간 13.7%의 연평균 복합 성장률(CAGR)로 50억 6,980만 달러에 이를 것으로 예상됩니다. 대상포진 치료제 시장에 대한 전반적인 분석, 시장 규모와 예측, 동향, 성장 촉진요인, 과제, 약 25개 벤더에 대한 벤더 분석 등의 정보를 전해드립니다.
현재의 시장 시나리오, 최신 동향 및 성장요인, 전체 시장 환경에 대한 최신 분석을 제공합니다. 대상포진 발병률 증가, 노인 인구 증가, 백신을 포함한 의약품에 대한 유리한 상환 정책 등이 시장을 주도하고 있습니다.
| 시장 범위 |
| 기준 연도 |
2024년 |
| 종료 연도 |
2028년 |
| 예측 기간 |
2024-2028년 |
| 성장 모멘텀 |
가속 |
| 전년 대비(2024년) |
11.8% |
| CAGR |
13.7% |
| 증분 금액 |
50억 6,980만 달러 |
이 보고서는 향후 몇 년동안 대상포진 치료제 시장의 성장을 가속하는 주요 요인 중 하나로 질병 관리를 위한 혁신적인 백신의 출현을 꼽았습니다. 또한, 백신 접종 프로그램, 무료 백신 제공 이니셔티브, 조사 확대 등도 시장 수요를 촉진하는 요인으로 작용할 것으로 보입니다.
목차
제1장 주요 요약
제2장 Technavio의 분석
- 가격 민감도, 수명주기, 고객 구입 바스켓, 채택 비율, 구입 기준 분석
- 인풋의 중요성과 차별화 요인
- 혼란 요인
- 성장 촉진요인과 과제의 영향
제3장 시장 구도
제4장 시장 규모
- 시장의 정의
- 시장 부문 분석
- 시장 규모, 2023년
- 시장 전망, 2023-2028년
제5장 시장 규모 실적
- 세계의 대상포진 치료제 시장, 2018-2022년
- 제품별 분석, 2018-2022년
- 지역별 분석, 2018-2022년
- 국가별 분석, 2018-2022년
제6장 정성 분석
- 대상포진 치료제 세계 시장에 대한 AI의 영향
제7장 Five Forces 분석
- Five Forces 요약
- 바이어의 교섭력
- 공급 기업의 교섭력
- 신규 진출업체의 위협
- 대체품의 위협
- 경쟁 위협
- 시장 현황
제8장 시장 세분화 : 제품별
- 시장 부문
- 비교 : 제품별
- 예방 접종 : 시장 규모와 예측, 2023-2028년
- 약제 요법 : 시장 규모와 예측, 2023-2028년
- 시장 기회 : 제품별
제9장 고객 상황
제10장 지역별 상황
- 지역별 세분화
- 지역별 비교
- 북미 : 시장 규모와 예측, 2023-2028년
- 유럽 : 시장 규모와 예측, 2023-2028년
- 아시아 : 시장 규모와 예측, 2023-2028년
- 세계 기타 지역 : 시장 규모와 예측, 2023-2028년
- 미국 : 시장 규모와 예측, 2023-2028년
- 독일 : 시장 규모와 예측, 2023-2028년
- 중국 : 시장 규모와 예측, 2023-2028년
- 캐나다 : 시장 규모와 예측, 2023-2028년
- 영국 : 시장 규모와 예측, 2023-2028년
- 프랑스 : 시장 규모와 예측, 2023-2028년
- 인도 : 시장 규모와 예측, 2023-2028년
- 일본 : 시장 규모와 예측, 2023-2028년
- 브라질 : 시장 규모와 예측, 2023-2028년
- 멕시코 : 시장 규모와 예측, 2023-2028년
- 시장 기회 : 지역 상황별
제11장 성장 촉진요인, 과제, 기회 및 성장 억제요인
- 시장 성장 촉진요인
- 시장이 해결해야 할 과제
- 성장 촉진요인과 과제의 영향
- 시장 기회와 성장 억제요인
제12장 경쟁 구도
제13장 경쟁 분석
- 기업 개요
- 기업 순위 지수
- 기업의 시장 포지셔닝
- Abbott Laboratories
- Bausch Health Companies Inc.
- Cipla Inc.
- Eli Lilly and Co.
- Emcure Pharmaceuticals Ltd.
- GlaxoSmithKline Plc
- Maruho Co. Ltd.
- Merck and Co. Inc.
- Novartis AG
- Zydus Lifesciences Ltd.
제14장 부록
LSH
Herpes Zoster Therapeutics Market 2024-2028
The herpes zoster therapeutics market is forecasted to grow by USD 5069.8 mn during 2023-2028, accelerating at a CAGR of 13.7% during the forecast period. The report on the herpes zoster therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increased incidence of herpes zoster, rising geriatric population, and favorable reimbursement policies for medications, including vaccines.
| Market Scope |
|---|
| Base Year | 2024 |
| End Year | 2028 |
| Series Year | 2024-2028 |
| Growth Momentum | Accelerate |
| YOY 2024 | 11.8% |
| CAGR | 13.7% |
| Incremental Value | $5069.8 mn |
Technavio's herpes zoster therapeutics market is segmented as below:
By Product
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
This study identifies the emerging innovative vaccines for disease management as one of the prime reasons driving the herpes zoster therapeutics market growth during the next few years. Also, vaccination programs and initiatives providing free vaccines and expanding research will lead to sizable demand in the market.
The report on the herpes zoster therapeutics market covers the following areas:
- Herpes Zoster Therapeutics Market sizing
- Herpes Zoster Therapeutics Market forecast
- Herpes Zoster Therapeutics Market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading herpes zoster therapeutics market vendors that include Abbott Laboratories, Bausch Health Companies Inc., Cipla Inc., East India Pharmaceutical Works Ltd., East West Pharma India Pvt. Ltd., Eli Lilly and Co., Emcure Pharmaceuticals Ltd., FDC Ltd., GeneOne Life Science Inc., GlaxoSmithKline Plc, Ikon Remedies Pvt. Ltd., Leeford Healthcare Ltd., Maruho Co. Ltd., Merck and Co. Inc., Novartis AG, Sanofi SA, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Viatris Inc., and Zydus Lifesciences Ltd.. Also, the herpes zoster therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
- 1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market By Geographical Landscape
- Executive Summary - Chart on Market Segmentation by Product
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning
2 Technavio Analysis
- 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- 2.2 Criticality of inputs and Factors of differentiation
- Overview on criticality of inputs and factors of differentiation
- 2.3 Factors of disruption
- Overview on factors of disruption
- 2.4 Impact of drivers and challenges
- Impact of drivers and challenges in 2023 and 2028
3 Market Landscape
- 3.1 Market ecosystem
- Parent Market
- Data Table on - Parent Market
- 3.2 Market characteristics
- Market characteristics analysis
- 3.3 Value chain analysis
4 Market Sizing
- 4.1 Market definition
- Offerings of companies included in the market definition
- 4.2 Market segment analysis
- 4.3 Market size 2023
- 4.4 Market outlook: Forecast for 2023-2028
- Chart on Global - Market size and forecast 2023-2028 ($ million)
- Data Table on Global - Market size and forecast 2023-2028 ($ million)
- Chart on Global Market: Year-over-year growth 2023-2028 (%)
- Data Table on Global Market: Year-over-year growth 2023-2028 (%)
5 Historic Market Size
- 5.1 Global Herpes Zoster Therapeutics Market 2018 - 2022
- Historic Market Size - Data Table on Global Herpes Zoster Therapeutics Market 2018 - 2022 ($ million)
- 5.2 Product segment analysis 2018 - 2022
- Historic Market Size - Product Segment 2018 - 2022 ($ million)
- 5.3 Geography segment analysis 2018 - 2022
- Historic Market Size - Geography Segment 2018 - 2022 ($ million)
- 5.4 Country segment analysis 2018 - 2022
- Historic Market Size - Country Segment 2018 - 2022 ($ million)
6 Qualitative Analysis
- 6.1 Impact of AI on Global Herpes Zoster Therapeutics Market
7 Five Forces Analysis
- 7.1 Five forces summary
- Five forces analysis - Comparison between 2023 and 2028
- 7.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2023 and 2028
- 7.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2023 and 2028
- 7.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2023 and 2028
- 7.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2023 and 2028
- 7.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2023 and 2028
- 7.7 Market condition
- Chart on Market condition - Five forces 2023 and 2028
8 Market Segmentation by Product
- 8.1 Market segments
- Chart on Product - Market share 2023-2028 (%)
- Data Table on Product - Market share 2023-2028 (%)
- 8.2 Comparison by Product
- Chart on Comparison by Product
- Data Table on Comparison by Product
- 8.3 Vaccination - Market size and forecast 2023-2028
- Chart on Vaccination - Market size and forecast 2023-2028 ($ million)
- Data Table on Vaccination - Market size and forecast 2023-2028 ($ million)
- Chart on Vaccination - Year-over-year growth 2023-2028 (%)
- Data Table on Vaccination - Year-over-year growth 2023-2028 (%)
- 8.4 Drug therapy - Market size and forecast 2023-2028
- Chart on Drug therapy - Market size and forecast 2023-2028 ($ million)
- Data Table on Drug therapy - Market size and forecast 2023-2028 ($ million)
- Chart on Drug therapy - Year-over-year growth 2023-2028 (%)
- Data Table on Drug therapy - Year-over-year growth 2023-2028 (%)
- 8.5 Market opportunity by Product
- Market opportunity by Product ($ million)
- Data Table on Market opportunity by Product ($ million)
9 Customer Landscape
- 9.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
10 Geographic Landscape
- 10.1 Geographic segmentation
- Chart on Market share By Geographical Landscape 2023-2028 (%)
- Data Table on Market share By Geographical Landscape 2023-2028 (%)
- 10.2 Geographic comparison
- Chart on Geographic comparison
- Data Table on Geographic comparison
- 10.3 North America - Market size and forecast 2023-2028
- Chart on North America - Market size and forecast 2023-2028 ($ million)
- Data Table on North America - Market size and forecast 2023-2028 ($ million)
- Chart on North America - Year-over-year growth 2023-2028 (%)
- Data Table on North America - Year-over-year growth 2023-2028 (%)
- 10.4 Europe - Market size and forecast 2023-2028
- Chart on Europe - Market size and forecast 2023-2028 ($ million)
- Data Table on Europe - Market size and forecast 2023-2028 ($ million)
- Chart on Europe - Year-over-year growth 2023-2028 (%)
- Data Table on Europe - Year-over-year growth 2023-2028 (%)
- 10.5 Asia - Market size and forecast 2023-2028
- Chart on Asia - Market size and forecast 2023-2028 ($ million)
- Data Table on Asia - Market size and forecast 2023-2028 ($ million)
- Chart on Asia - Year-over-year growth 2023-2028 (%)
- Data Table on Asia - Year-over-year growth 2023-2028 (%)
- 10.6 Rest of World (ROW) - Market size and forecast 2023-2028
- Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- 10.7 US - Market size and forecast 2023-2028
- Chart on US - Market size and forecast 2023-2028 ($ million)
- Data Table on US - Market size and forecast 2023-2028 ($ million)
- Chart on US - Year-over-year growth 2023-2028 (%)
- Data Table on US - Year-over-year growth 2023-2028 (%)
- 10.8 Germany - Market size and forecast 2023-2028
- Chart on Germany - Market size and forecast 2023-2028 ($ million)
- Data Table on Germany - Market size and forecast 2023-2028 ($ million)
- Chart on Germany - Year-over-year growth 2023-2028 (%)
- Data Table on Germany - Year-over-year growth 2023-2028 (%)
- 10.9 China - Market size and forecast 2023-2028
- Chart on China - Market size and forecast 2023-2028 ($ million)
- Data Table on China - Market size and forecast 2023-2028 ($ million)
- Chart on China - Year-over-year growth 2023-2028 (%)
- Data Table on China - Year-over-year growth 2023-2028 (%)
- 10.10 Canada - Market size and forecast 2023-2028
- Chart on Canada - Market size and forecast 2023-2028 ($ million)
- Data Table on Canada - Market size and forecast 2023-2028 ($ million)
- Chart on Canada - Year-over-year growth 2023-2028 (%)
- Data Table on Canada - Year-over-year growth 2023-2028 (%)
- 10.11 UK - Market size and forecast 2023-2028
- Chart on UK - Market size and forecast 2023-2028 ($ million)
- Data Table on UK - Market size and forecast 2023-2028 ($ million)
- Chart on UK - Year-over-year growth 2023-2028 (%)
- Data Table on UK - Year-over-year growth 2023-2028 (%)
- 10.12 France - Market size and forecast 2023-2028
- Chart on France - Market size and forecast 2023-2028 ($ million)
- Data Table on France - Market size and forecast 2023-2028 ($ million)
- Chart on France - Year-over-year growth 2023-2028 (%)
- Data Table on France - Year-over-year growth 2023-2028 (%)
- 10.13 India - Market size and forecast 2023-2028
- Chart on India - Market size and forecast 2023-2028 ($ million)
- Data Table on India - Market size and forecast 2023-2028 ($ million)
- Chart on India - Year-over-year growth 2023-2028 (%)
- Data Table on India - Year-over-year growth 2023-2028 (%)
- 10.14 Japan - Market size and forecast 2023-2028
- Chart on Japan - Market size and forecast 2023-2028 ($ million)
- Data Table on Japan - Market size and forecast 2023-2028 ($ million)
- Chart on Japan - Year-over-year growth 2023-2028 (%)
- Data Table on Japan - Year-over-year growth 2023-2028 (%)
- 10.15 Brazil - Market size and forecast 2023-2028
- Chart on Brazil - Market size and forecast 2023-2028 ($ million)
- Data Table on Brazil - Market size and forecast 2023-2028 ($ million)
- Chart on Brazil - Year-over-year growth 2023-2028 (%)
- Data Table on Brazil - Year-over-year growth 2023-2028 (%)
- 10.16 Mexico - Market size and forecast 2023-2028
- Chart on Mexico - Market size and forecast 2023-2028 ($ million)
- Data Table on Mexico - Market size and forecast 2023-2028 ($ million)
- Chart on Mexico - Year-over-year growth 2023-2028 (%)
- Data Table on Mexico - Year-over-year growth 2023-2028 (%)
- 10.17 Market opportunity By Geographical Landscape
- Market opportunity By Geographical Landscape ($ million)
- Data Tables on Market opportunity By Geographical Landscape ($ million)
11 Drivers, Challenges, and Opportunity/Restraints
- 11.1 Market drivers
- 11.2 Market challenges
- 11.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2023 and 2028
- 11.4 Market opportunities/restraints
12 Competitive Landscape
- 12.1 Overview
- 12.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
- 12.3 Landscape disruption
- Overview on factors of disruption
- 12.4 Industry risks
- Impact of key risks on business
13 Competitive Analysis
- 13.1 Companies profiled
- 13.2 Company ranking index
- 13.3 Market positioning of companies
- Matrix on companies position and classification
- 13.4 Abbott Laboratories
- Abbott Laboratories - Overview
- Abbott Laboratories - Business segments
- Abbott Laboratories - Key news
- Abbott Laboratories - Key offerings
- Abbott Laboratories - Segment focus
- SWOT
- 13.5 Bausch Health Companies Inc.
- Bausch Health Companies Inc. - Overview
- Bausch Health Companies Inc. - Business segments
- Bausch Health Companies Inc. - Key news
- Bausch Health Companies Inc. - Key offerings
- Bausch Health Companies Inc. - Segment focus
- SWOT
- 13.6 Cipla Inc.
- Cipla Inc. - Overview
- Cipla Inc. - Business segments
- Cipla Inc. - Key news
- Cipla Inc. - Key offerings
- Cipla Inc. - Segment focus
- SWOT
- 13.7 Eli Lilly and Co.
- Eli Lilly and Co. - Overview
- Eli Lilly and Co. - Product / Service
- Eli Lilly and Co. - Key offerings
- SWOT
- 13.8 Emcure Pharmaceuticals Ltd.
- Emcure Pharmaceuticals Ltd. - Overview
- Emcure Pharmaceuticals Ltd. - Product / Service
- Emcure Pharmaceuticals Ltd. - Key offerings
- SWOT
- 13.9 GlaxoSmithKline Plc
- GlaxoSmithKline Plc - Overview
- GlaxoSmithKline Plc - Business segments
- GlaxoSmithKline Plc - Key news
- GlaxoSmithKline Plc - Key offerings
- GlaxoSmithKline Plc - Segment focus
- SWOT
- 13.10 Maruho Co. Ltd.
- Maruho Co. Ltd. - Overview
- Maruho Co. Ltd. - Product / Service
- Maruho Co. Ltd. - Key offerings
- SWOT
- 13.11 Merck and Co. Inc.
- Merck and Co. Inc. - Overview
- Merck and Co. Inc. - Business segments
- Merck and Co. Inc. - Key news
- Merck and Co. Inc. - Key offerings
- Merck and Co. Inc. - Segment focus
- SWOT
- 13.12 Novartis AG
- Novartis AG - Overview
- Novartis AG - Business segments
- Novartis AG - Key news
- Novartis AG - Key offerings
- Novartis AG - Segment focus
- SWOT
- 13.13 Zydus Lifesciences Ltd.
- Zydus Lifesciences Ltd. - Overview
- Zydus Lifesciences Ltd. - Business segments
- Zydus Lifesciences Ltd. - Key news
- Zydus Lifesciences Ltd. - Key offerings
- Zydus Lifesciences Ltd. - Segment focus
- SWOT
14 Appendix
- 14.1 Scope of the report
- 14.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
- 14.3 Currency conversion rates for US$
- Currency conversion rates for US$
- 14.4 Research methodology
- 14.5 Data procurement
- 14.6 Data validation
- 14.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
- 14.8 Data synthesis
- 14.9 360 degree market analysis
- 360 degree market analysis
- 14.10 List of abbreviations
